Revenue cycle management has traditionally been viewed as the operational process that converts healthcare services into payment. For healthcare executives, that definition is increasingly inadequate. Revenue cycle performance now intersects with payer behavior, clinical workflows, technology, patient access, regulatory requirements, data quality, contract performance, and organizational financial strategy.
The result is an environment in which relatively small failures across the revenue life cycle can accumulate into significant financial exposure. Eligibility issues, authorization failures, inaccurate charge capture, coding errors, preventable denials, payer underpayments, aging accounts receivable, and weak contract oversight can each delay or reduce reimbursement.
At the same time, these vulnerabilities create opportunities. Organizations capable of identifying where revenue is being delayed, reduced, or lost—and understanding why—can move from reactive revenue cycle management toward a more strategic model of revenue protection and performance improvement.
For healthcare leadership, the central question is therefore no longer simply, “How efficiently are we billing?” It is: How effectively does the organization convert the care it delivers into accurate, timely, and contractually appropriate reimbursement?
Financial Pressure Is Raising the Importance of Revenue Cycle Performance
The financial environment surrounding healthcare organizations makes this question increasingly important.
MedPAC reported that hospitals’ fee-for-service Medicare margin was approximately –13% in 2023, excluding coronavirus relief funds, and projected a similar margin for 2025. While this measure should not be interpreted as an overall hospital profitability benchmark, it illustrates the reimbursement pressure surrounding a major payer segment.
Against that backdrop, avoidable revenue cycle friction becomes more consequential. A claim that requires rework, a payment that does not match contracted reimbursement, or a service delayed by authorization requirements consumes organizational resources while also affecting cash flow.
Administrative complexity carries its own financial burden. The 2024 CAQH Index estimated approximately $83 billion in annual administrative spending for the medical industry across the transactions it studied and identified approximately $18.4 billion in potential annual savings through further automation.
For healthcare organizations, those findings reinforce an important principle: revenue cycle improvement is not solely about collecting more money. It is also about reducing the cost, labor, delays, and operational friction required to collect reimbursement that is already due.
Strategic Risk #1: Denials Are Becoming a Revenue Protection Issue
Claim denials remain one of the most visible indications of revenue cycle performance problems.
HFMA reported that 11.65% of healthcare claims were denied on first pass in 2025. HFMA also cited an estimate that appealing a denied claim costs providers approximately $57.23 per claim, with the total cost of fighting claim denials exceeding $25 billion nationally in 2023.
The financial exposure created by denials extends beyond the denied dollars themselves.
Every preventable denial may generate additional touches from registration, authorization, coding, billing, clinical documentation, managed care, and follow-up teams. Some claims are corrected and recovered. Others remain unresolved long enough to increase accounts receivable or ultimately become write-offs.
This makes denial rate alone an incomplete executive metric.
Healthcare organizations should understand:
- Which payers generate the greatest denial volume and dollars.
- Which denial categories create the greatest financial exposure.
- What percentage of denials are preventable.
- How long appeals take to resolve.
- What percentage of denied dollars is eventually recovered.
- Which operational departments or workflows are generating recurring root causes.
Organizations that only manage denials after they occur remain in a reactive cycle. The larger opportunity is to use denial data to redesign upstream processes.
Strategic Risk #2: Prior Authorization Is Both an Access and Revenue Cycle Challenge
Prior authorization increasingly affects the intersection between patient access, clinical operations, and revenue realization.
The American Medical Association’s 2026 physician survey found that physicians and their staff completed an average of 40 prior authorizations per physician each week, requiring approximately 13 hours of physician and staff time. The survey also reported that 74% of responding physicians believed denials had increased during the previous five years.
Government oversight has raised related concerns. In a 2026 review, the HHS Office of Inspector General found that 19 Medicare Advantage organizations collectively denied 12% of prior authorization requests for skilled nursing facility admission during the month examined and raised concerns regarding initial denials that were subsequently overturned.
For providers, authorization performance has multiple consequences. Failure to secure authorization can result in denied reimbursement. Delays can disrupt scheduling and treatment. Repeated payer requirements increase administrative workload. Poorly documented authorization workflows may make it difficult to determine where accountability lies when payment is denied.
Organizations should therefore treat prior authorization metrics as part of revenue cycle governance rather than simply as patient-access statistics.
Strategic Risk #3: Contracted Revenue Does Not Automatically Become Collected Revenue
Another significant vulnerability occurs after the payer processes the claim.
Payment does not necessarily mean correct payment.
Healthcare organizations may have hundreds of reimbursement methodologies operating simultaneously across commercial, Medicare Advantage, Medicaid managed care, and other agreements. Rates may depend on fee schedules, case rates, percent-of-charge arrangements, bundled methodologies, multiple procedure reductions, carve-outs, modifiers, or other contract provisions.
Without reliable expected-reimbursement modeling, organizations can struggle to determine whether payments comply with negotiated agreements.
This creates a potentially important distinction between accounts receivable management and revenue integrity.
An account can be considered paid while still being underpaid.
Healthcare leaders should therefore examine expected-versus-actual reimbursement, payment variance trends, payer-specific underpayments, contract configuration accuracy, and recurring reimbursement discrepancies alongside traditional revenue cycle measures.
Strategic Risk #4: Fragmented Data Can Hide Financial Problems
Revenue cycle leaders often have access to substantial amounts of data but limited visibility across the complete revenue life cycle.
Registration systems, electronic health records, contract management platforms, clearinghouses, payer portals, billing systems, denial work queues, and financial reporting systems may each contain part of the story.
When those datasets are evaluated separately, executives may see the result of a problem without seeing its cause.
For example, an increase in accounts receivable could reflect payer processing delays, authorization failures, coding backlogs, claim edits, staffing constraints, or contract configuration issues. A single high-level KPI cannot distinguish among them.
Effective revenue cycle analytics should therefore connect financial outcomes to operational causes.
Leadership dashboards should move beyond reporting what happened and help answer:
Where is revenue at risk? Why is it at risk? Which payer, process, service line, location, or workflow is responsible? What action should be taken?
Strategic Opportunity #1: Shift From Denial Management to Denial Prevention
One of the clearest opportunities is moving analytical attention upstream.
Organizations should identify recurring root causes and determine whether interventions are needed in scheduling, eligibility verification, authorization, documentation, coding, charge capture, claim edits, payer configuration, or other workflows.
Rather than evaluating only aggregate denial percentages, leaders should segment denial performance by payer, reason, department, service line, location, provider, financial value, and preventability.
This transforms denial data from an operational work queue into management intelligence.
Strategic Opportunity #2: Strengthen Revenue Integrity
Revenue integrity connects clinical activity, documentation, charging, coding, reimbursement, and financial reporting.
Organizations should periodically evaluate whether services performed are consistently documented, charged, coded, billed, and reimbursed appropriately.
Potential areas of focus include charge capture, charge description master governance, fee schedule maintenance, coding accuracy, payment variance analysis, and revenue reconciliation.
The objective is not simply to increase charges. It is to create greater confidence that the organization’s financial systems accurately represent the services delivered and the reimbursement expected.
Strategic Opportunity #3: Use Automation Strategically
Technology can reduce manual effort, but automation should support well-designed processes rather than compensate for poorly understood ones.
CMS’s 2024 Interoperability and Prior Authorization Final Rule provides an important example of the direction of the industry. Impacted payers are subject to requirements intended to streamline prior authorization and expand electronic health information exchange, with several API requirements generally beginning in 2027. Certain operational provisions began in 2026.
Healthcare organizations should consider how automation can improve eligibility, authorization, claim-status workflows, denial identification, payment variance detection, and executive reporting.
But technology investments should begin with a measurable business problem. Leaders should ask what manual activity will be eliminated, what financial risk will become more visible, how accuracy will be monitored, and how performance will be measured after implementation.
Strategic Opportunity #4: Build Stronger Revenue Cycle Governance
Sustainable improvement requires accountability across departments.
Revenue cycle performance is influenced by patient access, clinical operations, coding, health information management, finance, managed care, IT, revenue integrity, and billing. No single department controls the complete process.
Organizations can strengthen governance by establishing a consistent performance framework with clearly defined metrics, owners, targets, escalation processes, and executive reporting.
A focused executive scorecard might include clean claim performance, initial denial rate, denial dollars, days in accounts receivable, aged receivables, authorization-related denials, underpayment recovery, expected-versus-actual reimbursement, charge lag, and payer-specific performance.
The specific measures should reflect the organization’s business model and financial priorities rather than relying solely on generic industry benchmarks.
Turning Revenue Cycle Risk Into Strategic Opportunity
Revenue cycle management should provide healthcare leaders with more than operational reporting. It should create financial visibility.
The organizations best positioned to strengthen revenue cycle performance will be those that connect operational processes with payer behavior, contractual reimbursement, technology, and financial analytics.
That requires a shift from asking whether claims were submitted and payments were received to examining whether reimbursement was accurate, whether preventable friction occurred, where revenue was placed at risk, and whether leaders have the information needed to intervene.
In an environment of reimbursement pressure and growing administrative complexity, effective revenue cycle management is increasingly a component of broader organizational resilience.
How Assurance Healthcare Advisors Can Help
Assurance Healthcare Advisors works with healthcare organizations to evaluate revenue cycle performance, identify reimbursement vulnerabilities, strengthen revenue integrity, analyze payer and payment performance, and develop practical strategies for financial and operational improvement.
A focused revenue cycle assessment can help leadership determine where financial risk is accumulating, which performance indicators deserve greater attention, and where targeted operational or analytical improvements may create measurable value.